Gene testing and reporting for Ovarian cancer specimens
- Hankija
- NHS Greater Glasgow and Clyde
- Avaldatud
- 2026-11-19
- Tähtaeg
- Pole esitatud
- Allikad
- UK_FTS
- Väärtus
- Pole esitatud
Kirjeldus
Kirjeldus on allika keeles.
NHS Greater Glasgow and Clyde, Laboratory Genetics requires an end-to-end diagnostic service for FFPE block processing, DNA based Homologous Repair Deficiency (HRD) and BRCA1 and BRCA2 gene testing and reporting for Ovarian cancer specimens. This service is required for approximately 200 tests per annum and the service must be available by 1st December 2026.
CPV: 85145000
Liikmesus
Teadete eelvaated on tasuta. Ametlike teadete ja dokumentide lingid, ehitusload ning isiklik MCP juurdepääs nõuavad aktiivset tasulist liikmesust.
Loe